Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Hyperphosphatemia Treatment Market?

In recent times, the market for hyperphosphatemia treatment has experienced considerable growth. The projections suggest an increase from $4.56 billion in 2024 to $5.08 billion in 2025, representing a compound annual growth rate (CAGR) of 11.4%. The historical growth can be traced back to factors such as an upsurge in the cases of chronic kidney disease (CKD), growing elderly population, rising rate of diabetes and hypertension, increase in the population of patients undergoing dialysis, as well as enhancements in medical research and hyperphosphatemia diagnostics.

The hyperphosphatemia treatment industry is predicted to experience significant expansion in the coming years, potentially reaching “$8.38 billion by 2029 with a 13.3% compound annual growth rate (CAGR). This projected growth in the market can be attributed to factors such as the increase in lifestyle-related diseases leading to hyperphosphatemia, a steady increase in the aging population, improved awareness and diagnosis of hyperphosphatemia, the growth of emerging markets carrying a heavy disease burden, and a higher proportion of calcium-based phosphate binder prescriptions in developing countries. Foreseen trends for this period include improvements in hyperphosphatemia treatment technology, the incorporation of telehealth and remote monitoring of patients, collaborative efforts in research and development, an emphasis on patient education and lifestyle management in regards to hyperphosphatemia, and the creation of innovative phosphate binders and therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5852&type=smp

Which Factor Is Shaping The Future Of The Hyperphosphatemia Treatment Market?

The surge in hyperphosphatemia treatment market can be attributed to the rise in chronic diseases among patients. These chronic ailments, which are non-communicable, necessitate long-standing care and largely include cardiovascular diseases, chronic kidney disease, chronic respiratory conditions, hyperparathyroidism, diabetes, and cancer. For instance, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported in September 2023 that there were 41 million deaths globally, 74% of which were caused by non-communicable or chronic diseases. Moreover, as per the report from SingleCare Services LLC, an American healthcare savings platform, in February 2023, the incidence of kidney diseases is escalating annually. Approximately 1 million lives are lost each year due to untreated kidney failure. The rising incidence of hyperphosphatemia in patients suffering from end-stage renal disease (ESRD) has consequently led to a surge in the demand for hyperphosphatemia treatments and medications.

What Is The Segment-Wise Breakdown Of The Hyperphosphatemia Treatment Market?

The hyperphosphatemia treatment market covered in this report is segmented –

1) By Product: Sevelamer, Calcium-Based Phosphate Binders, Iron-Based Phosphate Binders, Lanthanum Carbonate, Other products

2) By Distribution channel: Hospital Pharmacy, Retail Pharmacy, Online stores

Subsegments:

1) By Sevelamer: Sevelamer Hydrochloride, Sevelamer Carbonate

2) By Calcium-Based Phosphate Binders: Calcium Acetate, Calcium Carbonate

3) By Iron-Based Phosphate Binders: Ferric Citrate, Ferric Sulfate

4) By Lanthanum Carbonate: Lanthanum Carbonate Hydrate

5) By Other Products: Magnesium-Based Phosphate Binders, Novel Phosphate Binders

What Future Market Trends Are Projected For The Hyperphosphatemia Treatment Industry?

A primary trend in the hyperphosphatemia treatment market is the intensified focus on research and development activities. Companies within this market are honing their efforts towards innovating therapies for kidney diseases and associated chronic conditions. To illustrate, Eurostat, a European Government agency, reported in April 2024 that Ile-de-France region in France boasted 2.4 million main human resources in the field of science and technology, the most in Europe, during 2023. Followed by this was the Comunidad de Madrid region in Spain, with a count of 1.2 million.

Which Companies Hold The Largest Market Share In The Hyperphosphatemia Treatment Sector?

Major companies operating in the hyperphosphatemia treatment market include Sanofi SA, Akebia Therapeutics Inc., Ardelyx Inc., Astellas Pharma Inc., Fresenius Medical Care AG & Co. KGaA, Lupin Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Ultragenyx Pharmaceutical Inc., Unicycive Therapeutics Inc., Vifor Pharma Management Ltd., Zeria Pharmaceutical Co. Ltd., Amgen Inc., AstraZeneca plc, Baxter International Inc., Beckman Coulter Inc., Cleveland Clinic, DaVita Inc., Kyowa Kirin Pharmaceuticals Co. Ltd., Mayo Clinic, OPKO Health Inc., Tenet Healthcare Corporation, UnitedHealth Group Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hyperphosphatemia-treatment-global-market-report

How Does Regional Performance Compare Across The Hyperphosphatemia Treatment Industry?

North America was the largest region in the hyperphosphatemia treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperphosphatemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5852&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model